MedTrace Logo

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

NCT06367075 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2025-07-18

No results posted yet for this study

Summary

This is a single-arm, multicenter trial of cadonilimab (AK104) with adriamycin in patients with first-line advanced soft tissue sarcoma. the primary objective is to evaluate objective response rate of cadonilimab with adriamycin.

Conditions

  • Advanced Soft-tissue Sarcoma

Interventions

DRUG

Cadonilimab

injectable solution

DRUG

Adriamycin

injectable solution

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Yunnan Cancer Hospital

    collaborator OTHER

  • The Affiliated Hospital Of Guizhou Medical University

    collaborator OTHER

  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER

  • Second Xiangya Hospital of Central South University

    collaborator OTHER

  • Xiangya Hospital of Central South University

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • jing chen, doctor · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-09
Primary Completion
2027-03-31
Completion
2029-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06367075 on ClinicalTrials.gov